Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 1, 2006, Pages 60-63

  Torlontano, Massimo ^a,d   Crocetti, Umberto ^a   Augello, Giovanni ^a   D'Aloiso, Leonardo ^a   Bonfitto, Nazario ^a   Varraso, Antonio ^a   Dicembrino, Franca ^a   Modoni, Sergio ^a   Frusciante, Vincenzo ^a   Giorgio, Anna Di ^a   Bruno, Rocco ^b   Filetti, Sebastiano ^c   Trischitta, Vincenzo ^c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Tinchi Pisticci Hospital   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SENSITIVITY ANALYSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADULT; CARCINOMA, PAPILLARY; FEMALE; GAMMA CAMERAS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NECK; RECOMBINANT PROTEINS; RECURRENCE; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN; WHOLE-BODY COUNTING;

EID: 30344488437     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1185     Document Type: Article

References (20)

1. Hedinger C, Williams ED, Sobin LH 1988 Histological typing of thyroid tumors. In: International histological classification of tumors, Vol. 11. Geneva: World Health Organization; Berlin: Springer; 1-18
2. Leenhardt L, Grosclaude F, Cherie-Challine L 2004 Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060
3. Chow S-M, Law SCK, Chan JKC, Au S-K, Yau S, Lau W-H 2003 Papillary microcarcinoma of the thyroid - prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40
4. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1147
5. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M 1998 Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute experience. Cancer 83:553-559
6. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
7. Mazzaferri EL, Kloos RT 2002 Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490-1498
8. 131I scanning. J Clin Endocrinol Metab 87:1486-1489
9. Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A 2002 Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87:1499-1501
10. 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol 148:19-24
11. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Fallahi P, Baschieri L 1995 Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 5:25-28
12. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673
13. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90-96
14. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D'Azzò G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S 2004 Follow-up of low-risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402-3407
15. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441
16. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reinere C, Sánchez Franco F, Toft A, Wiersinga WM 2004 Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150:105-112
17. American Joint Committee on Cancer 2002 Thyroid. In: Greene FL, Page BL, Fleming ID, Fritz A, Balch CM, Haller BG, Morrow M, eds. AJCC cancer staging handbook. 6th ed. Chapter 8. New York: Springer; 89-98
18. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941-1946
19. Torrens JI, Burch HB 2001 Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metab Clin North Am 30:429-467
20. Wiseman GA 1996 Procedure 5-5: neck/total body scan. In: O'Connor MK, ed. The Mayo Clinic manual of nuclear medicine. London: Churchill Livingstone; 237-244